Sheaff Brock Investment Advisors LLC Has $3.36 Million Holdings in UnitedHealth Group Incorporated (UNH)

Sheaff Brock Investment Advisors LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 6.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 18,094 shares of the healthcare conglomerate’s stock after selling 1,332 shares during the quarter. Sheaff Brock Investment Advisors LLC’s holdings in UnitedHealth Group were worth $3,355,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the business. WMS Partners LLC grew its stake in shares of UnitedHealth Group by 0.8% in the 2nd quarter. WMS Partners LLC now owns 2,530 shares of the healthcare conglomerate’s stock valued at $469,000 after purchasing an additional 20 shares during the last quarter. Fiduciary Trust Co. boosted its stake in shares of UnitedHealth Group by 38.7% in the second quarter. Fiduciary Trust Co. now owns 51,798 shares of the healthcare conglomerate’s stock valued at $9,605,000 after buying an additional 14,449 shares in the last quarter. Manchester Capital Management LLC boosted its stake in shares of UnitedHealth Group by 2.4% in the second quarter. Manchester Capital Management LLC now owns 7,755 shares of the healthcare conglomerate’s stock valued at $1,438,000 after buying an additional 180 shares in the last quarter. Veritas Investment Management LLP boosted its stake in shares of UnitedHealth Group by 5.1% in the second quarter. Veritas Investment Management LLP now owns 444,471 shares of the healthcare conglomerate’s stock valued at $82,392,000 after buying an additional 21,539 shares in the last quarter. Finally, Spectrum Management Group Inc. boosted its stake in shares of UnitedHealth Group by 16.7% in the second quarter. Spectrum Management Group Inc. now owns 2,765 shares of the healthcare conglomerate’s stock valued at $513,000 after buying an additional 395 shares in the last quarter. Institutional investors own 86.17% of the company’s stock.

UnitedHealth Group Incorporated (NYSE:UNH) opened at $211.07 on Friday. The company has a market capitalization of $205,015.92, a price-to-earnings ratio of 22.04, a P/E/G ratio of 1.57 and a beta of 0.64. UnitedHealth Group Incorporated has a 12 month low of $146.01 and a 12 month high of $213.93. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.72.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.57 by $0.09. The firm had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.17 earnings per share. equities analysts predict that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be paid a $0.75 dividend. The ex-dividend date is Thursday, November 30th. This represents a $3.00 annualized dividend and a yield of 1.42%. UnitedHealth Group’s payout ratio is currently 33.26%.

UNH has been the topic of a number of analyst reports. UBS AG restated an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, August 24th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Morgan Stanley lifted their price target on UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a research note on Wednesday, October 18th. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Finally, Leerink Swann restated a “buy” rating and issued a $240.00 price target (up from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Three equities research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and an average target price of $216.65.

In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the sale, the director now owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Thomas E. Roos sold 975 shares of the business’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the sale, the insider now directly owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The disclosure for this sale can be found here. Insiders sold 72,149 shares of company stock valued at $14,212,342 over the last quarter. Insiders own 0.89% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Sheaff Brock Investment Advisors LLC Has $3.36 Million Holdings in UnitedHealth Group Incorporated (UNH)” was posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The original version of this news story can be accessed at https://www.chaffeybreeze.com/2017/11/12/sheaff-brock-investment-advisors-llc-has-3-36-million-holdings-in-unitedhealth-group-incorporated-unh.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply